Navigation Links
Alpha and Omega Gene Therapy Eye Cream's Scientific Blend Removes Years of Damage
Date:12/19/2013

PHILADELPHIA, Dec. 19, 2013 /PRNewswire/ -- E'Shee Clinical Esthetic announced the launch of a new eye cream product that is designed to target wrinkles, sagging skin, dark circles and puffiness. But, unlike other eye creams, this Alpha and Omega gene therapy eye cream is a scientifically-advanced blend of innovative ingredients.       

(Photo: http://photos.prnewswire.com/prnh/20131219/LA36083)

"Supremely-advanced restoration and care for the eyes and lips is what this product delivers," Nataly Giter, founder, E'shee Clinical Esthetic, says.  

E'shee's eye cream has a light creamy texture and includes ingredients such as patented aFGF (acidic fibroblast growth factor), far-infrared powder and Botox-like peptides. It's designed for the most delicate facial skin and works to remove years and years of skin damage and negligence.

aFGF is a bioengineered growth factor identical to the natural growth factor found in the human body and can provide fast, skin-repairing effects while dramatically speeding up the skin-renewal process. And, far infrared powder, produced from natural elements, can absorb outside heat energy and then release it. It recharges aging or dying cells which may explain why a far infrared ray with this healing wavelength is called "life light."

In addition to the usual benefits of fine line disappearance, deep wrinkle reduction and firmer and healthier skin, gene therapy eye cream users will also realize better texture; rebuild extra cellular matrix and restore its function; and reduce puffiness through improved blood circulation and toxin removal.

Alpha and Omega gene therapy cream also works to reduce redness caused by rosacea; helps to repair broken capillaries; and can help to heal scar tissue resulting from burns or acne.

"Stronger and improved skin is typically seen within 28 days," Giter says.

E'Shee Clinical Esthetic recommends this gene therapy eye cream for all skin types and ages. It's a non-greasy and fast-absorbing formula that does not clog pores.

About E'shee Clinical Esthetic:

E'shee was launched in 2009 by Nataly Giter, a hands-on skin care professional with more than 20 years of experience. Through research and practical experience, she learned about the most effective ingredients for advanced skin care and became associated with Dr. Chiu, a professor from Ohio University and the first global pioneer to clone the human FGF-1 gene.

Together, with their combined connections to industry professionals, they used FGF-1 to create an extraordinary anti-aging product line, using 99 percent pure FGF-1 peptide - the best quality available outside of the human body.

For more information on E'shee Clinical Esthetic, visit: www.esheeesthetic.com or http://www.esheeesthetic.com/wordpress/.

- Photo 72dpi: http://send2press.com/mediaboom/13-1218-eshee-eyecream_400x300.jpg

- Photo Caption: Alpha and Omega Gene Therapy Eye Cream.

This release was issued through Send2Press(R), a unit of Neotrope(R). For more information, visit Send2Press Press Release Distribution at http://www.Send2Press.com


'/>"/>
SOURCE E'shee Clinical Esthetic
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alpha Imaging Acquires Tristar Midatlantic Imaging
2. U.S. Gastroenterologists Have Increased Their TNF-alpha Inhibitor Use Since 2012, Especially for AbbVies Humira, as a Result of Its Recent Approval in Ulcerative Colitis
3. The Michael J. Fox Foundation Leads Charge to Develop Alpha-Synuclein PET Tracer to Image Parkinsons Disease Biomarker
4. Harrisvaccines, Inc. Secures Exclusive Rights From AlphaVax, Inc. to Develop RNA Particle Vaccines for All Diseases in Companion Animals
5. Uroplasty To Participate In The Craig-Hallum Alpha Select Conference
6. IRIDEX to Present at Craig-Hallum 4th Annual Alpha Select Conference
7. Cardica To Present At Craig-Hallum Alpha Select Conference
8. Carolus Therapeutics and The Alpha-1 Project Collaborate to Validate CT-2009 Target as Important in Human Disease
9. Synthetically Optimized HIF-1 Alpha DNA Delivered with Inovios Electroporation Technology Provides Significant Therapeutic Effects for Peripheral Arterial Disease in Animal Model
10. CoMentis and Anvyl Announce Formation of Alpharmagen, a Joint Venture to explore Nicotinic Modulators
11. ImmunGene and Collaborators Report Positive Results in Pre-clinical Studies of Novel Anti-CD20 Antibody-Interferon Alpha Fusion Protein
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... BASEL, Switzerland and SAN DIEGO ... Houston , Inc., a global leader in viral gene ... gene therapy treatments for congestive heart failure and other ... to develop a scalable manufacturing process and produce cGMP-grade ... clinical trials. --> ...
(Date:2/10/2016)... NEW YORK , Feb. 10, 2016 ... clinical-stage biopharmaceutical company, announced today that it has filed ... Myeloid Leukemia and other cancers. --> ... of treating cancer by administration of Ceplene (histamine dihydrochloride) ... also provides methods of predicting the efficacy of Ceplene ...
(Date:2/10/2016)... , Feb. 10, 2016  Oxis International Inc. ... drug, OXS-1550, was described as a "clinical trial triumph" ... drug went into complete cancer remission. ... of Minnesota Masonic Cancer Center. --> ... of Minnesota Masonic Cancer Center. --> ...
Breaking Medicine Technology:
(Date:2/10/2016)... Massachusetts (PRWEB) , ... February 10, 2016 , ... ... models to effectively measure change in their patients. Research shows that the Goal ... methods. To help therapists overcome this challenge and learn more about the Goal ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... has been awarded the prestigious Distinguished Emerald Club of the World award, as ... BoardRoom magazine, one of the most respected trade publications serving private clubs. , ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... FL 32224, February 26th: Amateur & Professional Divisions - Time: 7:00pm – ... – 10:00pm | Ticket Prices $30, Social Media: http://www.USPoleSportsFed.org , Facebook: ...
(Date:2/10/2016)... ... February 10, 2016 , ... The recreational use of marijuana has ... state still face a lot of restrictions as to where they can smoke pot. ... personal use” and that cannabis “may not be consumed openly or publicly.” , Given ...
(Date:2/10/2016)... Puente, California (PRWEB) , ... February 09, 2016 ... ... Medicine students, faculty and staff helped give free oral screenings to 150 children ... Feb. 5, 2016. , The College of Dental Medicine joined Chinese American Dental ...
Breaking Medicine News(10 mins):